SOPHiA GENETICS (SOPH) Assets (2020 - 2026)

SOPHiA GENETICS has disclosed Assets across 7 years of filings, most recently posting $198.4 million for Q2 2026.

• In Q2 2026, Assets rose 11.68% year-over-year to $198.4 million; the TTM figure through Jun 2026 stood at $198.4 million (up 11.68% YoY), while the FY2025 annual figure was $163.0 million, up 4.97% from the prior year.
• Assets came in at $198.4 million for Q2 2026 at SOPHiA GENETICS, up from $157.0 million in the prior quarter.
• In the past five years, Assets ranged from a high of $297.6 million in Q1 2022 to a low of $146.7 million in Q1 2025.
• Average Assets over 5 years is $202.1 million, with a median of $189.7 million recorded in 2024.
• The largest YoY upside for Assets was 166.45% in 2022 against a maximum downside of 25.18% in 2022.
• Over 5 years, Assets stood at $243.8 million in 2022, then slipped by 15.45% to $206.2 million in 2023, then retreated by 24.66% to $155.3 million in 2024, then gained by 4.97% to $163.0 million in 2025, then increased by 21.67% to $198.4 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $198.4 million in Q2 2026, $157.0 million in Q1 2026, and $163.0 million in Q4 2025.